Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 75/100

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Tuesday, September 5, 2023 1 min read
Key Takeaway: CytomX Therapeutics, Inc. has announced its participation in two key investor conferences this September, aiming to engage with investors and provide insights into the company’s developments. The H.C. Wainwright 25th Annual Global Investment Conference will take place on September 12, followed by the Cantor Global Healthcare Conference on September 26. Both events will feature presentations and Q&A sessions, with opportunities for one-on-one meetings for registered investors. This initiative reflects CytomX's commitment to investor relations and transparency.

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX is actively engaging with investors, showcasing transparency.
  • Participation in prestigious investor conferences indicates strong market interest.
  • Live webcasts offer accessibility for broader investor engagement.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will participate in the following investor conferences in September.
H.C. Wainwright 25th Annual Global Investment Conference
Date: Tuesday, September 12, 2023
Company Presentation: 11:30 a.m. ET
Location: New York, NY
Cantor Global Healthcare Conference
Date: Tuesday, September 26, 2023
Fireside Chat: 8:10 a.m. ET
Location: New York, NY
Live webcasts of the H.C. Wainwright presentation and Cantor fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations
stephanie.ascher@sternir.com

Frequently Asked Questions

When will CytomX present at the H.C. Wainwright conference?

CytomX will present on September 12, 2023, at 11:30 a.m. ET.

What is the date of the Cantor Global Healthcare Conference?

The Cantor Global Healthcare Conference is on September 26, 2023.

Where can I watch CytomX's conference presentations live?

Live webcasts will be available on CytomX's Events and Presentations page.

Will there be one-on-one investor meetings?

Yes, management will meet with registered investors at the conferences.

What is CytomX Therapeutics known for?

CytomX is a leader in conditionally activated, localized biologics.

Tags: CTMX Viatris Investor Conferences Healthcare CytomX investor conferences biologics H.C. Wainwright
Last updated: Sep 5, 2023